Certolizumab pegol Completed Phase 4 Trials for Rheumatoid Arthritis

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT01098201Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)